Share statistics (as at 9 April 2019)
|Number of Ordinary Shares in issue (undiluted)||204,660,267|
|Number of Ordinary Shares subject to options||5,950,000|
|Maximum number of Ordinary Shares in issue (fully diluted)||213,855,080|
The effect of the options, if all were exercised, would be to increase the issued share capital by 2.91% and raise £2,313,050 for the Company.
There are no restrictions on the transfer of Futura Medical plc shares.
Major shareholders (as at 9 April 2019)
Shareholders holding more than 3% of the share capital of Futura were:
|Lombard Odier Asset Management (Europe) Limited||17.51%|
|WT Lamb Investments Limited||4.49%|
Shares not in public hands (as at 9 April 2019)
In terms of the AIM Rules and insofar as it is aware, 25.97% of the Company's AIM securities are not in public hands.
Shares held in treasury (as at 9 April 2019)
In terms of the AIM Rules, there are no shares held in treasury.
Share volumes (as at 9 April 2019)
The daily average number of shares traded since 2013 is:
|Daily Average Per Year Since 2013 ('000)||Daily Average Per Month in 2019 ('000)|
Share options (as at 9 April 2019)
The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:
|Grant||Exercise period (incl)||Exercise price/share||No of share options granted||Cash to Company on exercise|
|09/12||10/14 - 09/19||61.50p||560,000||£344,400|
|09/13||10/15 - 09/20||71.50p||620,000||£443,300|
|09/14||10/16 - 09/21||51.75p||580,000||£300,150|
|09/15||10/17 - 09/22||30.00p||750,000||£225,000|
|01/17||10/18 - 09/23||57.50p||960,000||£552,000|
|09/17||10/19 - 09/24||30.50p||1,140,000||£347,700|
|11/18||10/20 - 09/25||7.50p||1,340,000||£100,500|
Further details of share options issued can be obtained from the Company's Annual Report 2017 which can be found in the Annual and Interim Reports section.
Page last updated: 10 April 2019